Kiniksa Pharmaceuticals International (KNSA) Receivables - Other (2022)
Kiniksa Pharmaceuticals International's (KNSA) quarterly Receivables - Other came in at $7.7 million in Q4 2022.
Kiniksa Pharmaceuticals International (KNSA) Receivables - Other (2022) Analysis & Trends
Kiniksa Pharmaceuticals International (KNSA) has 1 years of Receivables - Other data on file, last reported at $7.7 million in Q4 2022.
- Quarterly Receivables - Other changed N/A year-over-year to $7.7 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $7.7 million (changed N/A YoY) and the FY2022 annual result came in at $7.7 million, changed N/A from the prior year.
- Receivables - Other held at $7.7 million in Q4 2022.
- In the past five years, Receivables - Other ranged from a high of $7.7 million in Q4 2022 to a low of $7.7 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Kiniksa Pharmaceuticals International | 6.07 Bn | 5.54 Bn | 220.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 7.66 Mn |
| Dec 31, 2022 | 7.66 Mn |